APOE and Alzheimer disease: No difference between AD patients with or without H63D (p-value not reported). Earlier onset in AD patients with H63D who are homozygous for ApoE4 (5.1 years earlier than ApoE4 heterozygotes; p = 0.014, and 6.1 years earlier than ApoE4 non-carriers; p = 0.019).